0001567619-22-021963.txt : 20221223 0001567619-22-021963.hdr.sgml : 20221223 20221223101750 ACCESSION NUMBER: 0001567619-22-021963 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221220 FILED AS OF DATE: 20221223 DATE AS OF CHANGE: 20221223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jarboe Matthew CENTRAL INDEX KEY: 0001887923 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40902 FILM NUMBER: 221483766 MAIL ADDRESS: STREET 1: C/O PARAGON 28, INC. STREET 2: 14445 GRASSLANDS DRIVE CITY: ENGLEWOOD STATE: CO ZIP: 80112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Paragon 28, Inc. CENTRAL INDEX KEY: 0001531978 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 273170186 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8310 SOUTH VALLEY HIGHWAY STREET 2: SUITE 3115 CITY: ENGLEWOOD STATE: CO ZIP: 80112 BUSINESS PHONE: 888-728-1888 MAIL ADDRESS: STREET 1: 8310 SOUTH VALLEY HIGHWAY STREET 2: SUITE 3115 CITY: ENGLEWOOD STATE: CO ZIP: 80112 4 1 doc1.xml FORM 4 X0306 4 2022-12-20 0 0001531978 Paragon 28, Inc. FNA 0001887923 Jarboe Matthew C/O PARAGON 28, INC. 14445 GRASSLANDS DRIVE ENGLEWOOD CO 80112 0 1 0 0 Chief Commercial Officer Common Stock 2022-12-20 4 M 0 62099 0.60 A 333863 D Common Stock 2022-12-20 4 S 0 62099 20.9133 D 271764 D Common Stock 2022-12-21 4 M 0 10023 0.60 A 281787 D Common Stock 2022-12-21 4 M 0 14890 1.20 A 296677 D Common Stock 2022-12-21 4 S 0 24913 20.9132 D 271764 D Stock Option (Right to Buy) 0.60 2022-12-20 4 M 0 62099 0.00 D 2025-12-31 Common Stock 62099 10023 D Stock Option (Right to Buy) 0.6 2022-12-21 4 M 0 10023 0 D 2025-12-31 Common Stock 10023 0 D Stock Option (Right to Buy) 1.20 2022-12-21 4 M 0 14890 0 D 2026-12-31 Common Stock 14890 60110 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.90 to $21.04 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 71,469 restricted stock units. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $20.90 to $20.95 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares subject to the option vest are fully vested and exercisable. /s/ Jonathan Friedman, as Attorney-in-Fact for Matthew Jarboe 2022-12-22